836
Views
102
CrossRef citations to date
0
Altmetric
Research Article

The role of estrogen in mood disorders in women

Pages 280-290 | Published online: 11 Jul 2009

References

  • ABRAMOWITZ, E. S., BAKER, A. H. & FLEISHCHER, S.F. (1982). Onset of depressive crises and the menstrual cycle. American Journal of Psychiatry, 139, 475–478.
  • AHoKAs, A., AITO, M. & RimcoN, R. (2000). Positive treatment effect of estradiol in postpartum psychosis: a pilot study. Journal of Clinical Psychiatry, 6/(3), 166–169.
  • AHOKAS, A., KAUKORANTA, J., WAHLBECK, K. & AITO, M. (2001). Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physio-logic 17-I3-estradiol: a preliminary study. Journal of Clinical Psychiatry, 62, 332–336.
  • ALTAR, C.A. (1999). Neurotrophins and depression. Trends in Pharmacological Sciences, 20, 59–61.
  • ALTMAN, N., SACHAR, E.J., GRUEN, P.H., HALPERN, F.S. & ETO, S. (1975). Reduced plasma LH concentration in postmenopausal depressed women. Psychosomatic Medicine, 37,274–276.
  • AMEIUCAN PSYCHIATRIC ASSOCIATION (1994). Diagnostic and Statistical Manual of Mental Disorders (4th edn). WASHINGTON, DC: American Psychiatric Association.
  • AMSTERDAM, J.D., WINOKUR, A., Juou, I. & SNYDER, P. (1983). Neuroendocrine regulation in depressed post-menopausal women and healthy subjects. Acta Psychiatrica Scandinavica, 67,43–49.
  • ASHBY C.R. JR, CAR, L.A., COOK, C.L., STEPTOE, M.M. & FRANKS, D.D. (1988). Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in pre-menstrual syndrome. Biological Psychiatry, 24, 225–233.
  • ASHBY, C.R. JR., CARR, L.A., COOK, C.L., STEPTOE, M.M. & FRANKS, D.D. (1990). Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. Journal of Neural Transmission, General Section, 79,41–50.
  • AVIS, N.E., BRAMBILLA, D., MCIUNLAY, S.M. & VASS, K. (1994). A longitudinal analysis of the association between menopause and depression: results from the Massachusetts women‘s health study. Annals of Epidemiology, 4, 214–220.
  • BARRETT-CONNER, E., VONMUHLEN, D., LAUGHLIN, G.A. & KRIPKE, A. (1999). Endogenous levels of dehydroepian-drosterone sulfate are associated with depressed mood in older women: the Rancho Bernadrdo study. Journal of American Geriatric Society, 47(6), 685–691.
  • BEBCHUK, J.M., ARFKEN, C.L., DONLAN-MANJI, S., MURPHY, J., HASANAT, K. & MANJI, H.K. (2000). A preliminary investigation of a Protein Kinase C inhibitor in the treatment of acute mania. Archives of General Psychiatry, 57,95–97.
  • BLOCH, M., SCHMIDT, P.J., DANACEAU, M., MURPHY, J., NIEMAN, L. & RUBINOW, D.R. (2000). Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry, 157, 924–930.
  • BRATFOS, O. & HAUG, J.O. (1966). Puerperal mental disorders in manic-depressive females. Acta Psychiatrica Scandinavica, 42, 285–294.
  • CAMPBELL, S.B. & Coym, J.F. (1991). Prevalence and correlates of postpartum depression in first-time mothers. Journal of Abnormal Psychology, 4, 594–599.
  • CHAKRAVORTY, S.G. & HALBREICH, U. (1997). The influence of estrogen on monoamine oxidase activity. Psychopharmacology Bulletin, 33(2), 229–233.
  • CHOUINARD, G., STEINBERG, S. & STEINER, W. (1987). Estrogen-progesterone combination: another mood stabilizer? American Journal of Psychiatry, 144, 826.
  • CLARKE, W.P. & MAAYANI, S. (1990). Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies. Brain Research, 518, 287–291.
  • COOPER, P.J., CAMPBELL, E.A., DAY, A., KENNERLEY, H. & BOND, A. (1988). Non-psychotic psychiatric disorder after childbirth: a prospective study of prevalence, incidence, course and nature. British Journal of Psychiatry, 152, 799–806.
  • Cox, J.L., MURRAY, D. & CHAPMAN, G. (1993). A controlled study of the ONSET, duration and prevalence of postnatal depression. British Journal of Psychiatry, 163, 27–31.
  • DALTON, K. (1959). Menstruation and acute psychiatric illnesses. British Medical journal, I, 148–149.
  • DAVIDSON, J. & ROBERSTON, E. (1985). A follow-up study of postpartum illness, 1946-1978. Acta Psychiatrica Scandinavica, 71, 451–457.
  • DICKINSON, S.L. & CURZON, G. (1986). 5-Hydroxytrypta-mine-mediated behavior in male and female rats. Neuropharmacology, 25, 771–776.
  • DROUVA, S.V., GrORENNE, I., LAPLANTE, E., RERAT, E., ENJALBERT, A. & KoRDoN, C. (1990). Estradiol mod-ulates Protein Kinase C activity in the rat pituitary in vivo and in vitro. Endocrinology, 126(1), 536–544.
  • DUMAN, R.S., MALBERG, J., NAKAGAWA, S. & D‘SA, C. (2000). Neuronal plasticity and survival in mood disorders. Biological Psychiatry, 48, 732–739.
  • DUMAN, R.S., HENINGER, G.R. & NESTLER, E.J. (1997). A molecular and cellular theory of depression. Archives of General Psychiatry, 54, 597–606.
  • ENDICOTT, J. (1993). The menstrual cycle and mood disorders. Journal of Affective Disorders, 29, 193–300.
  • ERIKSSON, E., HEDBERG, M.A., ANDERSCH, B. & SUNDBLAD, C. (1995). The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology, 12, 167–176.
  • FRANK, E., KUPFER, D.J., JACOB, M., BLUMENTHAL, S.J. & JARRETT, D.B. (1987). Pregnancy-related affective episodes among women with recurrent depression. American Journal of Psychiatry, 144, 288–293.
  • FREEMAN, E.W., RICICELS, K., SONDHEIMER, S.J. & POLANSKY, M. (1999). Differential response to anti-depressants in women with premenstrual syndrome/ premenstrual dysphoric disorder. Archives of General Psychiatry, 56, 932–939.
  • GIBBS, R.B. (1998). Levels of trkA and BDNF mRNA but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Research, 787, 259–268.
  • GIBBS, R.B. (1999). Treatment with estrogen and proges-terone affects relative levels of brain-derived neuro-trophic factor mRNA and protein in different regions of the adult rat brain. Brain Research, 844, 20–27.
  • GITLIN M.J. & PASNAU, R.O. (1989). Psychiatric syndromes linked to reproductive function in women: a review of current knowledge. American Journal of Psychiatry, 146, 1413–1422.
  • GRAZE, K.K., NEE, J. & ENDICOTT, J. (1990). Premenstrual depression predicts future major depressive disorder. Acta Psychiatrica Scandinavica, 81, 201–205.
  • GREGOIRE, A.J.P., KUMAN, R., EVERITT, B., HENDERSON, A.F. & STUDD, J.W. (1996). Transdermal oestrogen for treatment of severe postnatal depression. Lancet, 347, 930–933.
  • GUICHENEY, P., LEGER, D., BARRAT, J., Tiztvoux, R., DE LIGNIERES, ROQUES, B., GARNIER, P., BOYER J.P.,, GRENIER, P., J. & DREUX, C. (1988). Platelet serotonin content and plasma tryptophan in pen- and postmeno-pausal women: variations with plasma oestrogen levels and depressive symptoms. European Journal of Clinical Investigations, 18, 297–304.
  • HALBREICH, U. & KAHN, L.S. (2001). Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs, 15(10), 797–817.
  • HARRIS, B. (1994). Biological and hormonal aspects of postpartum depressed mood: working towards strategies for prophylaxis and treatment. British Journal of Psychiatry, 164, 288–292.
  • HARRIS, B., JOHNS, S., FUNG, H., THOMAS, R., WALKER, R., READ, G. & RIAD-FAMMY, D. (1989). The hormonal environment of postnatal depression. British Journal of Psychiatry, 154, 660–667.
  • HOLSBOER, R., BENKERT, O. & DEMISCH, L. (1983). Changes in MAO activity during estrogen treatment of female with endogenous depression. Modern Problems in Phannacopsychiatiy, 19, 321–326.
  • JOFFE, H. & COHEN, L.S. (1998). Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biological Psychiatry, 44, 798–811.
  • KAREGE, F., PERRET, G., BONDOLFI, G., SCHWALD, M., BERTSCHY, G. & AUBRY, J.-M. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research, 109, 143–148.
  • KATNELLENBOGEN, B.S. (1996). Estrogen receptors: bioactivities and interactions with cell signaling. Biology of Reproduction, 54(2), 287–293.
  • KENDALL, D.A., STANCEL, G.M. & ENNA, S.J. (1982). The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. Journal of Neuroscience, 2, 354–360.
  • KENDELL, R.E., CHALMER, J. C. & PLATZ, C. (1987). Epidemiology of puerperal psychoses. British Journal of Psychiatry, 150, 662–673.
  • KESSLER, R.C., MCGONAGLE, K.A., SWARTZ, M., BLAZER, D.G. & NELSON, C.B. (1993). Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity, and recurrence. Journal of Affective Disorders, 29, 85–96.
  • KESSLER, R.C., MCGONAGLE, K.A., ZHAO, S., NELSON, C.B., HUGHES, M., ESHLEMAN, S., WITTCHEN, H.-U. & KENDLER, K.S. (1994). Lifetime and 12-month pre-valence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry, 51, 8–19.
  • KLAIBER, E.L., BROVERMAN, D.M., BOGET, W. & KOBAYABI, Y. (1979). Estrogen therapy for severe persistent depressions in women. Archives of General Psychiatry, 36,550–554.
  • KUMAR, R. & ROBSON, K.M. (1984). A prospective study of emotional disorders in childbearing women. British Journal of Psychiatry, 144, 35–47.
  • LEIBENLUFT, E. (1996). Women with bipolar illness: clinical and research issues. American Journal of Psychiatry, 153, 163–173.
  • LEWIN, G.R. & BARDE, Y.A. (1996). Physiology of neurotrophins. Annual Review of Neuroscience, 19, 289–317.
  • Liu, Y., FOWLER, C.D., YOUNG, L.J., YAN, Q., INSEL, T.R. & WANG, Z. (2001). Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles. The Journal of Comparative Neurology, 433, 499–514.
  • LINDSAY, R.M., WIEGRAND, S.J., ALTAR, C.A. & DI STEFANO, S. (1994). Neurotrophic factors: from mole-cule to man. Trends in Neuroscience, 17, 182–289.
  • LYONS, W.E., MAMOUNAS, L.A., RICAURTE, G.A., COPPOLA, V., REID, S.W., BORA, S.H., WIHLER, C., KOLIATSOS, V.E. & TESSAROLLO, L. (1999). Brain-derived neuro-trophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proceedings of the National Academy of Science, USA, 96,15239–15244.
  • MAEDA, T. & LLOYD, R.V. (1993). Protein Kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue. Laboratory Investigation, 68(4), 472–480.
  • MAIZELS, E.T., MILLER, J.B., CUTLER, R.E. JR, JAcraw, V., CARNEY, E.M., MIZUNO, K., OHO, S. & HUNZICKER-DuNN, M. (1992). Estrogen modulates Ca (2±)-inde-pendent lipid-stimulated kinase in the rabbit corpus luteum of pseudopregnancy. Identification of luteal estrogen-modulated lipid-stimulated kinase as protein kinase c delta. Journal of Biological Chemistry, 267(24), 17061–17068.
  • MANJI, H.K. & LENOX, R.H. (1999). Protein Kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biological Psychiatry, 46, 1328–1351.
  • MAMOUNAS, L.A., BLUE, M.E., SIUCIAK, J.A. & ALTAR, C.A. (1995). Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in the mouse brain. Journal of Neuroscience, 15, 7929–7939.
  • McEwEN, B.S., ALVES, S.E., BuliocH, K. & WEILAND, N.G. (1998). Clinically relevant basic sciences studies of gender differences and sex hormones effects. Psycho-pharmacology Bulletin, 34, 251–259.
  • McEwEN, B.S. & ALVES, S.H. (1999). Estrogen actions in the central nervous system. Endocrine Reviews, 20, 279–307.
  • McEwEN, B. (2002). Estrogen actions throughout the brain. Recent Progress in Hormone Research, 57, 357–384.
  • NEVES-PEREIRA, M., MUNDO, E., MUGLIA, P., KING, N., MACCIARDI, F., & KENNEDY, J.L. (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. American Journal of Human Genetics, 71, 651–656.
  • NIBUYA, M., MORINABU, S. & DUMAN, S. (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience, 15, 7539–7547.
  • NIBUYA, M., TAKAHAsm, M., RUSSELL, S.S. & DUMAN, R.S. (1999). Chronic stress increases catalytic TrkB mRNA in rat hippocampus. Neuroscience letters, 267(2), 81–84.
  • NOTT, P.N., FRANKLIN, M., ARMITAGE, C. & GELDER, M.G. (1976). Hormonal changes and mood in the puerper-ium. British Journal of Psychiatry, 128, 379–383.
  • HARA o, M.W., SCHLECHTE, J.A., LEWIS, D.A. & WRIGHT, E.J. (1991a). Prospective study of postpartum blues, biologic and psychosocial factors. Archives of General Psychiatry, 48, 801–806.
  • HARAo, M.W., SCHLECHTE, J.A., LEWIS, D.A. & VARNER, M.W. (1991b). Controlled prospective study of post-partum mood disorders: psychological, environmental, and hormonal variables. Journal of Abnormal Psychology, 100, 63–73.
  • OHKURA, T., TESHIMA, Y. & ISSE, K. (1994). Estrogen increases cerebral and cerebellar blood flow in post-menopausal women. Menopause, 2, 13–18.
  • OINONEY, K.A. & MAZMANIAN, D. (2002). To what extent do oral contraceptives influence mood and affect? Journal of Affective Disorders, 70, 229–240.
  • OPPENHEIM, G. (1984). A case report of rapid cycling with estrogen: implications for therapy. Journal of Clinical Psychiatry, 45, 34–35.
  • PILGRIM, C. & HUTCHISON, J.B. (1994). Developmental regulation of sex differences in the brain: can the role of gonadal steroids be redefined? Neuroscience, 60(4), 843–855.
  • PRANGE, A.J. (1972). Estrogen may well affect response to antidepressants. Journal of the American Medical Association, 219, 143–144.
  • RAPKIN, A.J., EDELMUTH, E., CHANG, L.C., READING, A.E., MCGUIRE, M.T. & Su, T.P. (1987). Whole-blood serotonin in premenstrual syndrome. Obstetrics and Gynecology, 70, 553–537.
  • REBAS, E., LACHOWICZ, A. & LACHOWICZ, L. (1995). Estradiol and pregnenolone sulfate could modulate PMA-stimulated and Ca2±/calmodulin-dependent synaptosomal membrane protein phosphorylation from rat brain in vivo. Biochemical and Biophysical Research Communications, 207(2), 606–612.
  • REICH, T. & WINOKUR, G. (1970). Postpartum psychosis in patients with manic-depressive disease. Journal of Nervous Mental Disease, 151, 60–68.
  • ROBINSON, G.E. & STEWART, D.E. (1986). Postpartum psychiatric disorders. Canadian Medical Association Journal, 134, 31–37.
  • RUBINOW, D.R., SCHMIDT, P.J. & ROCA, C.A. (1998). Hormone measures in reproductive endocrine-related mood disorders: diagnostic issues. Psychopharmacology Bulletin, 34(4), 289–290.
  • SCHMIDT, P.J., NEIMAN, L.K., DANAEAU, M.A., ADAMS, L.F. & RUBINOW, D.R. (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine, 338, 209–216.
  • SCHMIDT, P.J., NEIMAN, L.K., DANACEAU, M.A., TOBIN, M.B., ROCA, C.A., MURPHY, J.H. & RUBINOW, D.R. (2000). Estrogen replacement in perimenopause-related depression: a preliminary report. American Journal of Obstetrics and Gynecology, 183, 414–420.
  • SCHMIDT, P.J. & RUBINOW, D.R. (1994). Menopause-related affective disorders: a justification for further study. American Journal of Psychiatry, 148, 844–852.
  • SCHMIDT, P.J. & RUBINOW, D.R. (2002). Reproductive hormonal treatments for mood disorders in women. Dialogues in Clinical Neuroscience, 4(2), 211–223.
  • SCHNEIDER, L. S., SMALL, G.W., HAMILTON, S. H., BYSTRITSKY, A., NEMEROFF, C.B. & MEYERS, B.S. (1997). Estrogen replacement and response to fluox-etine in a multicenter geriatric depression trial: fluox-etine collaborative study group. American journal of Geriatric Psychiatry, 5, 97–106.
  • SCHNEIDER, L.S., SMALL, G.W. & CLARY, C.M. (2001). Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. American Journal of Geriatric Psychiatry, 9(4), 393–399.
  • SHAPIRA, B., OPPENHEIM, G. & ZOHAR, J. (1985). Lack of efficacy of estrogen supplementation to imipramine in resistant female depressive. Biological Psychiatry, 20, 576–579.
  • SHELTON, R.C. (2000). Cellular mechanisms in the vulnerability to depression response to antidepressants. The Psychiatric Clinics of North America, 23, 713–729.
  • SICHEL, D.A., COHEN, L. S., ROBERTSON, L.M., RUTIENBERG, A. & ROSENBAUM, J. F. (1995). Prophylactic estrogen in recurrent postpartum affective disorder. Biological Psychiatry, 38, 814–818.
  • SIUCIAK, J.A., LEWIS, D. & WIEGAND, S.J. (1997). Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacological and Biochemical Behavior, 56,131–137.
  • SIUCIAK, J.A., ALTAR, C.A., WIGAND, S.J. & LINDSAY, R.M. (1994). Antinoceptive effect of brain-derived neuro-tropic factor and neurotrophin-3. Brain Research, 633, 326–330.
  • SIUCIAK, J.A., BOYLAN, C., FRITSCHE, M., ALTAR, C.A. & LINDSAY, R.M. (1996). BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Research, 710, 11–20.
  • SKLAR, P., GABIUEL, S.B., MCINNIS, M.G., BENNETT, P., Lim, Y.-M., TSAN, G., SCHAFFNER, S., KIROV, G., JONES, I., OWEN, M., CRADDOCK, N., DEPAULO, J.R. & LANDER, E.S. (2002). Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Molecular Psychiatry, 7, 579–593.
  • SmITH, M.A., MAKINO, S., KVETNANSKY, R. & POST, R.M. (1995). Effects of stress on neurotrophic factor expres-sion in the rat brain. Annals of New York Academy of Sciences, 771, 234–239.
  • SOARES, C.N., ALMEIDA, O.P., JOFFE, H. & COHEN, L.S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Archives of General Psychiatry, 58(6), 529–534.
  • STEINER, M., STEINBERG, S., STEWART, D., CARTER, D., BERGER, C., REID, R., GROVER, D. & STREINER, D. (1995). Fluoxetine in the treatment of premenstrual syndrome. New England journal of Medicine, 332, 1529–1534.
  • STEWART, D.E. & BOYDELL, K.M. (1993). Psychologic distress during menopause: associations across the reproductive life cycle. International Journal of Psychiany in Medicine, 23, 157–162.
  • Su, T.-P., SCHMIDT, P.J., DANACEAU, M.A., TomN, M.B., ROSENSTEIN, D.L., MURPHY, D.L. & RumNow, D.R. (1997). Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology, 16, 346–356.
  • THOMAS, M.L., BLAND, D.A., CL, C.H. & CUNNINGHAM, K.A. (1997). Estrogen regulation of serotonin (5-HT) transporter and 5-HT1A receptor mRNA in female rat brain. Abstracts of Society for Neuroscience, 23, 1501.
  • UGARIUZA, D.N. (1992). Postpartum affective disorders: incidence and treatment. Journal of Psychosocial Nursing, 30(5), 29–32.
  • WEILAND, N.G. (1992). Estradiol selectively regulates agonist-binding sites on the N-methyl-u-aspartate recep-tor complex in the CA1 region of the hippocampus. Endocrinology, 131, 662–668.
  • WETZEL, R.D., REICH, T., MCCLURE, J.N. & WALD, J.A. (1975). Premenstrual affective syndrome and affective disorder. British Journal of Psychiatry, 127, 219–221.
  • WiEcK, A. (1989). Endocrine aspects of postnatal mental disorders. Baillieres Best Practice and Research: Clinical Obstetrics and Gynaecology, 3, 857–877.
  • WISNER, K.L. & STowE, Z.N. (1997). Psychobiology of postpartum mood disorders. Seminars in Reproductive Endocrinology, 15(1), 77–89.
  • WOOLLEY, C. & McEwEN, B.S. (1992). Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. Journal of Neuroscience, 12, 2549–2554.
  • WOOLLEY, C.S., WETLAND, N.G., McEwEN, B.S. & SCHWARTZKROIN, P.A. (1997). Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. Journal of Neuroscience, 17, 1848–1859.
  • YoNKERs, K. (1997). The association between premenstr-ual dysphoric disorder and other mood disorders. Journal of Clinical Psychiatry, 58(Suppl 15), 19–25.
  • YONKERS, K. & WHITE, K.L. (1992). Premenstrual exacer-bation of depression: one process or two? Journal of Clinical Psychiatry, 53, 289–292.
  • YONKERS, K.A., HALBREICH, U., FREEMAN, E.W., BROWN, C., ENDICOTT, J., FRANK, E., PARRY, B., PEARLSTEIN, T SEVERINO, S., STOUT, A., STONE, A. & HARRISON, W. (1997). Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. Journal of the American Medical Association, 278, 983–988.
  • YOUNG, RC., MOLINE, M. & KLEYMAN, F. (1997). Hormone replacement therapy and late-life mania. American Journal of Geriatric Psychiatry, 5, 179–181.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.